UPB Upstream Bio Inc.

  1. Stocks
  2. Healthcare
  3. NASDAQ: UPB

Price (delayed)

$5.19

Market cap

$284.26M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.89

Enterprise value

$205.62M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 25
Highlights
The debt has declined by 39% year-on-year and by 14% since the previous quarter
The quick ratio has declined by 27% year-on-year but it is up by 21% since the previous quarter
The revenue is up by 16% year-on-year but it has declined by 4.9% since the previous quarter
The EPS has shrunk by 166% YoY
UPB's net income is down by 50% year-on-year
Sector: Healthcare
Industry: Biotechnology
Website: https://upstreambio.com
Peers: AMGN GILD VRTX REGN

Key stats

What are the main financial stats of UPB

UPB stock price

How has the Upstream Bio stock price performed over time
Intraday
-5.46%
1 week
-2.63%
1 month
-25.54%
1 year
-68.12%
YTD
-80.88%
QTD
-25%

Financial performance

How have Upstream Bio's revenue and profit performed over time
Revenue
$3.16M
Gross profit
$3.16M
Operating income
-$169.98M
Net income
-$156.5M
Gross margin
100%
Net margin
-4,955.7%
UPB's net income is down by 50% year-on-year
UPB's operating income is down by 40% year-on-year
The net margin has declined by 29% year-on-year and by 5% since the previous quarter
UPB's operating margin is down by 21% year-on-year and by 4% since the previous quarter

Price vs fundamentals

How does UPB's price correlate with its fundamentals

Growth

What is Upstream Bio's growth rate over time

Valuation

What is Upstream Bio stock price valuation
P/E
N/A
P/B
1.04
P/S
89.68
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
65.11
The EPS has shrunk by 166% YoY
The P/B is 56% less than the last 4 quarters average of 2.5
The company's equity fell by 34% YoY and by 11% QoQ
The stock's price to sales (P/S) is 67% less than its last 4 quarters average of 285.4
The revenue is up by 16% year-on-year but it has declined by 4.9% since the previous quarter

Efficiency

How efficient is Upstream Bio business performance
The company's return on invested capital has shrunk by 70% YoY and by 18% QoQ
UPB's ROA has dropped by 68% year-on-year and by 10% since the previous quarter
The ROS fell by 29% YoY and by 5% QoQ
The return on equity has declined by 28% year-on-year and by 11% since the previous quarter

Dividends

What is UPB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for UPB.

Financial health

How did Upstream Bio financials performed over time
Upstream Bio's total assets has decreased by 33% YoY and by 12% QoQ
The quick ratio has declined by 27% year-on-year but it is up by 21% since the previous quarter
The debt is 100% smaller than the equity
The debt has declined by 39% year-on-year and by 14% since the previous quarter
The company's equity fell by 34% YoY and by 11% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.